416 related articles for article (PubMed ID: 28795765)
1. Vitamin D predictors in polycystic ovary syndrome: a meta-analysis.
Bacopoulou F; Kolias E; Efthymiou V; Antonopoulos CN; Charmandari E
Eur J Clin Invest; 2017 Oct; 47(10):746-755. PubMed ID: 28795765
[TBL] [Abstract][Full Text] [Related]
2. Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: Relationships with obesity and insulin resistance.
Naderpoor N; Shorakae S; Abell SK; Mousa A; Joham AE; Moran LJ; Stepto NK; Spritzer PM; Teede HJ; de Courten B
J Steroid Biochem Mol Biol; 2018 Mar; 177():209-215. PubMed ID: 28734987
[TBL] [Abstract][Full Text] [Related]
3. Comparison of 25-hydroxyvitamin D and metabolic parameters between women with and without polycystic ovarian syndrome.
Ng BK; Lee CL; Lim PS; Othman H; Ismail NAM
Horm Mol Biol Clin Investig; 2017 Jun; 31(3):. PubMed ID: 28586302
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China.
Wang L; Lv S; Li F; Yu X; Bai E; Yang X
Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394
[No Abstract] [Full Text] [Related]
5. Intrinsic factors rather than vitamin D deficiency are related to insulin resistance in lean women with polycystic ovary syndrome.
Sahin S; Eroglu M; Selcuk S; Turkgeldi L; Kozali S; Davutoglu S; Muhcu M
Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2851-6. PubMed ID: 25339479
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of biochemical, endocrine, and metabolic biomarkers for the early diagnosis of polycystic ovary syndrome among non-obese Saudi women.
Daghestani MH
Int J Gynaecol Obstet; 2018 Aug; 142(2):162-169. PubMed ID: 29745981
[TBL] [Abstract][Full Text] [Related]
7. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome.
Wehr E; Pilz S; Schweighofer N; Giuliani A; Kopera D; Pieber TR; Obermayer-Pietsch B
Eur J Endocrinol; 2009 Oct; 161(4):575-82. PubMed ID: 19628650
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities.
Figurová J; Dravecká I; Javorský M; Petríková J; Lazúrová I
Wien Klin Wochenschr; 2016 Sep; 128(17-18):641-8. PubMed ID: 25787215
[TBL] [Abstract][Full Text] [Related]
9. Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome.
Hahn S; Haselhorst U; Tan S; Quadbeck B; Schmidt M; Roesler S; Kimmig R; Mann K; Janssen OE
Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):577-83. PubMed ID: 17177140
[TBL] [Abstract][Full Text] [Related]
10. Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome.
Yildizhan R; Kurdoglu M; Adali E; Kolusari A; Yildizhan B; Sahin HG; Kamaci M
Arch Gynecol Obstet; 2009 Oct; 280(4):559-63. PubMed ID: 19214546
[TBL] [Abstract][Full Text] [Related]
11. The Predictive Role of Serum Cystatin C Levels in Polycystic Ovary Syndrome in Adolescents.
Çınar M; Aksoy RT; Güzel Aİ; Tokmak A; Çandar T; Taşçı Y
J Pediatr Adolesc Gynecol; 2016 Aug; 29(4):353-6. PubMed ID: 26740281
[TBL] [Abstract][Full Text] [Related]
12. Serum Vitamin D Binding Protein Level Associated with Metabolic Cardiovascular Risk Factors in Women with the Polycystic Ovary Syndrome.
Kuliczkowska-Plaksej J; Pasquali R; Milewicz A; Lwow F; Jedrzejuk D; Bolanowski M
Horm Metab Res; 2019 Jan; 51(1):54-61. PubMed ID: 30408832
[TBL] [Abstract][Full Text] [Related]
13. 25-Hydroxyvitamin D levels are related to hyperinsulinemia in polycystic ovary syndrome.
Güdücü N; Görmüş U; Kutay SS; Kavak ZN; Dünder I
Gynecol Endocrinol; 2014 Aug; 30(8):557-60. PubMed ID: 24819314
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome.
Li HW; Brereton RE; Anderson RA; Wallace AM; Ho CK
Metabolism; 2011 Oct; 60(10):1475-81. PubMed ID: 21550088
[TBL] [Abstract][Full Text] [Related]
15. Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome.
Panidis D; Balaris C; Farmakiotis D; Rousso D; Kourtis A; Balaris V; Katsikis I; Zournatzi V; Diamanti-Kandarakis E
Clin Chem; 2005 Sep; 51(9):1691-7. PubMed ID: 16037412
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the association of vitamin D deficiency with gonadotropins and sex hormone in obese and non-obese women with polycystic ovary syndrome.
Velija-Ašimi Z
Med Glas (Zenica); 2014 Feb; 11(1):170-6. PubMed ID: 24496360
[TBL] [Abstract][Full Text] [Related]
17. Dietary intake, glucose metabolism and sex hormones in women with polycystic ovary syndrome (PCOS) compared with women with non-PCOS-related infertility.
Tsai YH; Wang TW; Wei HJ; Hsu CY; Ho HJ; Chen WH; Young R; Liaw CM; Chao JC
Br J Nutr; 2013 Jun; 109(12):2190-8. PubMed ID: 23046530
[TBL] [Abstract][Full Text] [Related]
18. Effect of vitamin D on clinical and biochemical parameters in polycystic ovary syndrome women: A meta-analysis.
Jia XZ; Wang YM; Zhang N; Guo LN; Zhen XL; Li H; Wei L
J Obstet Gynaecol Res; 2015 Nov; 41(11):1791-802. PubMed ID: 26370491
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D Levels in Women with Polycystic Ovary Syndrome: A Population-Based Study.
Lumme J; Sebert S; Pesonen P; Piltonen T; Järvelin MR; Herzig KH; Auvinen J; Ojaniemi M; Niinimäki M
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31752304
[TBL] [Abstract][Full Text] [Related]
20. Serum adiponectin in women with polycystic ovarian syndrome and its relation to clinical, metabolic and endocrine parameters.
Sieminska L; Marek B; Kos-Kudla B; Niedziolka D; Kajdaniuk D; Nowak M; Glogowska-Szelag J
J Endocrinol Invest; 2004 Jun; 27(6):528-34. PubMed ID: 15717649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
